Author： Wu J.H.
Publisher： Adis International
ISSN： 1175-9046
Source： Pharmaceutical Development and Regulation, Vol.1, Iss.4, 2003-01, pp. : 231-244
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
US FDA addresses postmarketing drug surveillance concerns
Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. :
US FDA addresses postmarketing drug surveillance concerns
Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. :